Page 133 - NobleCon21

Ocugen, Inc.

SELECTED FINANCIAL ITEMS OCGN
(in millions of USD)
CQ4 '24 CQ1 '25 CQ2 '25 CQ3 '25 LTM
Income Statement Key Items
Total Revenue 0.76 1.48 1.37 1.75 5.37
Gross Profit (7.53) 0.70 (7.03) (9.40) (23.26)
Gross Margin -985% 47% -512% -536% -433%
EBIT (13.84) (14.50) (13.80) (18.94) (61.08)
EBIT Margin -1812% -979% -1005% -1081% -1137%
Net Income to Common Shareholders (13.88) (15.35) (14.74) (20.05) (64.02)
Net Margin -1817% -1036% -1073% -1144% -1192%

Balance Sheet Key Items
Total Assets 82.44 64.46 53.59 57.60 57.60
Cash & Short Term Investments 58.51 37.80 27.01 32.57 32.57
% of Assets 71% 59% 50% 57% 57%
Current Assets -Total 61.68 43.96 32.88 37.64 37.64
% of Assets 75% 68% 61% 65% 65%
Total Liabilities 52.81 48.55 50.54 54.06 54.06
% of Assets 64% 75% 94% 94% 94%
Current Liabilities - Total 21.59 16.89 17.99 20.36 20.36
% of Assets 26% 26% 34% 35% 35%
Long Term Debt 27.35 27.67 28.03 28.40 28.40
% of Assets 33% 43% 52% 49% 49%
Total Equity 29.63 15.91 3.05 3.53 3.53
% of Assets 36% 25% 6% 6% 6%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (10.36) (19.36) (10.73) (12.92) (53.37)
Net Cash Flow - Investing (0.01) (0.10) (0.09) (0.09) (0.29)
Net Cash Flow - Financing 30.17 (1.25) 0.06 18.51 47.50

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference